Literature DB >> 24615441

Animal models of autoimmune neuropathy.

Betty Soliven.   

Abstract

The peripheral nervous system (PNS) comprises the cranial nerves, the spinal nerves with their roots and rami, dorsal root ganglia neurons, the peripheral nerves, and peripheral components of the autonomic nervous system. Cell-mediated or antibody-mediated immune attack on the PNS results in distinct clinical syndromes, which are classified based on the tempo of illness, PNS component(s) involved, and the culprit antigen(s) identified. Insights into the pathogenesis of autoimmune neuropathy have been provided by ex vivo immunologic studies, biopsy materials, electrophysiologic studies, and experimental models. This review article summarizes earlier seminal observations and highlights the recent progress in our understanding of immunopathogenesis of autoimmune neuropathies based on data from animal models.

Entities:  

Keywords:  Guillain-Barré syndrome; anti-ganglioside antibodies; chronic inflammatory demyelinating polyradiculoneuropathy [CIDP]; experimental autoimmune neuritis [EAN]; inflammatory neuropathy; myelin proteins; spontaneous autoimmune polyneuropathy [SAP]

Mesh:

Substances:

Year:  2014        PMID: 24615441      PMCID: PMC3962258          DOI: 10.1093/ilar/ilt054

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  116 in total

1.  Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants.

Authors:  M Mäurer; C D Schmid; F Bootz; J Zielasek; K V Toyka; S Oehen; R Martini
Journal:  Mol Cell Neurosci       Date:  2001-06       Impact factor: 4.314

2.  Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies.

Authors:  Kate Townson; Judith Boffey; Dawn Nicholl; Jean Veitch; David Bundle; Ping Zhang; Eric Samain; Tatiana Antoine; Anna Bernardi; Daniela Arosio; Sandro Sonnino; Neil Isaacs; Hugh J Willison
Journal:  Glycobiology       Date:  2006-12-04       Impact factor: 4.313

3.  Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein.

Authors:  S W Brostoff; S Levit; J M Powers
Journal:  Nature       Date:  1977-08-25       Impact factor: 49.962

4.  CD28 ligation in T-cell activation: evidence for two signal transduction pathways.

Authors:  J A Ledbetter; J B Imboden; G L Schieven; L S Grosmaire; P S Rabinovitch; T Lindsten; C B Thompson; C H June
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

5.  Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.

Authors:  Ralf A Linker; De-Hyung Lee; Seray Demir; Stefan Wiese; Niels Kruse; Ines Siglienti; Ellen Gerhardt; Harald Neumann; Michael Sendtner; Fred Lühder; Ralf Gold
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

6.  Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide.

Authors:  Katsuichi Miyamoto; Sachiko Miyake; Melitta Schachner; Takashi Yamamura
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

7.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

8.  Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy.

Authors:  Kazuo Takada; Jun Shimizu; Susumu Kusunoki
Journal:  Exp Neurol       Date:  2007-09-21       Impact factor: 5.330

9.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.

Authors:  C Linington; S Izumo; M Suzuki; K Uyemura; R Meyermann; H Wekerle
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

View more
  13 in total

1.  Guillain-Barré Syndrome During the Postpartum Period.

Authors:  Mohammed Aabdi; Yassine Mellagui; Amine Bensaid; Houssam Bkiyar; Brahim Housni
Journal:  Cureus       Date:  2020-12-10

2.  Transcriptomes in rat sciatic nerves at different stages of experimental autoimmune neuritis determined by RNA sequencing.

Authors:  Y Xue; P Yin; G Li; D Zhong
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

Review 3.  Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Authors:  Jolien Wolbert; Mandy I Cheng; Gerd Meyer zu Horste; Maureen A Su
Journal:  JCI Insight       Date:  2020-02-13

4.  A novel prognostic system based on clinical and laboratory parameters for childhood Guillain-Barre syndrome.

Authors:  Ishita Tiwari; Areesha Alam; Chandra Kanta; Sciddhartha Koonwar; Ravindra Kumar Garg; Shweta Pandey; Amita Jain; Rashmi Kumar
Journal:  Acta Neurol Belg       Date:  2022-06-26       Impact factor: 2.471

5.  Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.

Authors:  John W Rumsey; Case Lorance; Max Jackson; Trevor Sasserath; Christopher W McAleer; Christopher J Long; Arindom Goswami; Melissa A Russo; Shruti M Raja; Karissa L Gable; Doug Emmett; Lisa D Hobson-Webb; Manisha Chopra; James F Howard; Jeffrey T Guptill; Michael J Storek; Miguel Alonso-Alonso; Nazem Atassi; Sandip Panicker; Graham Parry; Timothy Hammond; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2022-04-05

Review 6.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 7.  Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.

Authors:  José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

8.  Virus-triggered spinal cord demyelination is followed by a peripheral neuropathy resembling features of Guillain-Barré Syndrome.

Authors:  Eva Leitzen; Barbara B Raddatz; Wen Jin; Sandra Goebbels; Klaus-Armin Nave; Wolfgang Baumgärtner; Florian Hansmann
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 9.  Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?

Authors:  Rudolf Martini; Hugh Willison
Journal:  Glia       Date:  2015-08-06       Impact factor: 7.452

Review 10.  Biological Drugs in Guillain-Barré Syndrome: An Update.

Authors:  Nazgol Motamed-Gorji; Nassim Matin; Omidreza Tabatabaie; Piero Pavone; Catia Romano; Raffaele Falsaperla; Giovanna Vitaliti
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.